Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086879
Status:
COMPLETED
Last Update Posted:
2017-07-27
First Post:
2004-07-08
Brief Title:
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-26034-16031
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None